Atracurium Besylate
CAS number: 64228-81-5
Molecular formula: C53H72N2O12.2(C6H5O3S)
molecular weight: 1243.48
Chemical structure:
Producers shown on SFDA
(Record date:05/09/2021)
Producer | Documents | GMP Valid till(based on SFDA) |
Lianyungang Guike Pharmaceutical Co., Ltd. | GMP, DMF | Valid till August 2021 |
Jiangsu Shengdi Pharmaceutical Co., Ltd. | GMP | Valid till February 2018 |
Jiangsu Hengrui Medicine Co.,Ltd. | GMP | Valid till December 2022 |
Producers shown on EP
Not showing any
Producer:Lianyungang Guike Pharmaceutical Co., Ltd., established in 2006, is a high-tech integrated pharmaceutical manufacturer focuses on research, development, production and sales of pharmaceutical raw material. Located at No. 1 Xianfeng Road, Dapu Industrial Park, Lianyungang Economic and technological development zone, and covers a total area of around 31148.9m2 with all facilities built strictly according to the GMP standard. The factory owns many internationally leading equipment imported from Europe and the United States. The products are popular for high quality and have customers in Japan, Korea, Russia, Belarus, Turkey, Pakistan, Indonesia, etc.
Staff size:50-99 people
Registered capital:RMB 43 million 23 thousand and 566
Producer:Founded in 2005, Jiangsu Shengdi Pharmaceutical Co., Ltd. is mainly engaged in the R & D and production of pharmaceutical raw materials, formerly known as the API branch of Jiangsu Hengrui Pharmaceutical Co., Ltd.
The company is now deregistered.
Staff size:/
Registered capital:RMB 50 million
Producer:Jiangsu Hengrui Medicine Co.,Ltd. is a pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs.
The company has 28000 employees globally, fifth R & D centers were built around the globe and several subsidiaries were established in the US, EU, and Japan
The company has 10 manufacturing facilities and most of them maintain USP, EUP, and JP. We are the first Chinese company that exported injections on a large scale to the US, EU, and Japan markets. All dosage forms of the company have passed the national GMP certification, and ifosfamide, etoposide, mesilar and tiotepa have passed the verification of FDA.
Staff size:About 30000 people
Registered capital:RMB 6 billion 397 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978